D-allulóz a szénhidrát- és zsíranyagcserében - Your Allulose Store

D-Allulose in carbohydrate and fat metabolism

Allulose Store

Source: DergiPark Academic

2019.

Due to changing living conditions, the incidence of obesity and obesity-related endocrine diseases has increased.


In addition to lifestyle changes, they also began to look for other treatment options to prevent these diseases.

D-Allulose is the third carbon epimer of fructose and is rarely found in nature.

Allulose exerts its effects through various mechanisms, including potent antioxidant effects, inhibitory activity against intestinal digestive enzymes, translocation of glucokinase from the liver nucleus to the cytoplasm, and competitive transport of glucose across the intestinal mucosa.

It also has antihyperlipidemic and antihypertriglyceridemic effects on fat metabolism.

Toxicity studies on rats with D-allulose did not show any adverse effects and it is considered safe.

Because it reduces monosaccharide absorption, enhances fatty acid oxidation, and suppresses glucose oxidation when administered orally, it can be considered an alternative treatment method in addition to lifestyle changes in the treatment of obesity and related diseases.

Keywords

Obesity  diabetes  carbohydrate metabolism  lipid metabolism

Source

  • 1. Ministry of Health of the Republic of Turkey, Turkish Public Health Institute. Turkey's Healthy Nutrition and Active Lifestyle Program. Ankara: Ministry of Health; 2013.
  • 2. Bereket A, Atay Z. Current status of childhood obesity and related morbidities in Turkey. Journal of Clinical Research in Pediatric Endocrinology. 2012; 4(1): 1-7.
  • 3. Yeşilkaya E, Cinaz P, Andıran N, Bideci A, Hatun Ş, Sarı E et al. The first report on the nationwide incidence and prevalence of type 1 diabetes among children in Turkey. Diabetic Medicine. 2017;34(3):405-10.
  • 4. TURDEP Working Group. Summary of the results of TURDEP-2. Satman I. 32nd TEMD Congress; 2010; Antalya.
  • 5. Giugliano D, Esposito K. Mediterranean diet and metabolic diseases. Current Opinion in Lipidology. 2008; 19(1): 63-8.
  • 6. Borges MC, Louzada ML, de Sá TH, Laverty AA, Parra DC, Garzillo JMF et al. Artificially sweetened beverages and the response to the global obesity crisis. PLoS Medicine. 2017;14(1):e1002195.
  • 7. WHO. Non-communicable diseases and their risk factors. London: The Lancet Global Health; [Last updated: 5 September 2018; Reference: 26 September 2018] Available: http://www.who.int/ncds/prevention/physical-activity/lancet-global-health-insufficient-physical-activity-2001-2016/en/.
  • 8. Asif M. Prevention and control of type 2 diabetes through lifestyle and dietary changes. Journal of Education and Health Promotion. 2014: 3(1): 1-8. doi: 10.4103/2277-9531.127541.
  • 9. Nagata Y, Mizuta N, Kanasaki A, Tanaka K. Rare sugars, d-allulose, d-tagatose, and d-sorbose, differentially modulate lipid metabolism in rats. Journal of the Science of Food and Agriculture. 2018; 98(5): 2020-6.
  • 10. Yan Tang S. Rare sugars: Applications and enzymatic production. Biocatalysis and Biotransformation. 2012; 1(2): 363-8.
  • 11. Matsuo T, Izumori K. Effects of dietary D-psychosis on diurnal changes in plasma glucose and insulin concentrations in rats. Bioscience, Biotechnology, and Biochemistry. 2006; 70(9): 2081-5.
  • 12. Hossain MA, Kitagaki S, Nakano D, Nishiyama A, Funamoto Y, Matsunaga T. The rare sugar D-psychosis improves insulin sensitivity and glucose tolerance in Otsuka Long–Evans Tokushima fatty (OLETF) rats with type 2 diabetes. Biochemical and Biophysical Research Communications. 2011; 405(1): 7-12.
  • 13. Iida T, Yamada T, Hayashi N, Okuma K, Izumori K, Ishii R. Reduction of abdominal fat deposition in rats by 8-week consumption of a newly developed sweetener made from high-fructose corn syrup. Food Chemistry. 2013; 138(2-3): 781-5.
  • 14. Hossain A, Yamaguchi F, Matsuo T, Tsukamoto I, Toyoda Y, Ogawa M, et al. A rare sugar, D-allulose: Potential role and therapeutic monitoring in the maintenance of obesity and type 2 diabetes. Pharmacology & Therapeutics. 2015;155:49-59.
  • 15. Braunstein C, Noronha J, Glenn A, Viguiliouk E, Noseworthy R, Khan, T, Kendall C, et al. The effects of low, catalytic doses of fructose and allulose on postprandial blood glucose metabolism in healthy subjects: The Fructose and Allulose Catalytic Effects (FACE) Study. Nutrients 2018; 10(6): 750.
  • 16. Kishida K, Iida T, Yamada T, Ferraris RP, Toyoda Y. Intestinal D-allulose transport is likely mediated by glucose transporter type 5 (GLUT5). The FASEB Journal. 2018: 32(Suppl 1); 757-1.
  • 17. Eble TE, Hoeksema H, Boyack GA, Savage GM. Psychofuranine. I. Discovery, isolation and properties, Antibiotics and Chemotherapy. 1959; 9(7): 419-20.
  • 18. Poonperm W, Takata G, Ando Y, Sahachaisaree V, Lumyong P. Efficient conversion of allitol to D-psicose by Bacillus pallidus Y25. Journal of Bioscience and Bioengineering. 2007; 103(3): 282-5.
  • 19. Zhang L, Mu W, Jiang B, Zhang T. Characterization of D-tagatose-3-epimerase from Rhodobacter sphaeroides that converts D-fructose to D-psicose. Biotechnology Letters. 2009; 31(6): 857-62.
  • 20. Fukada K, Ishii T, Tanaka K, Yamaji, Yamaoka Y, Kobashi KI et al. Crystal structure, solubility and mutarotation of the rare monosaccharide D-psychose. Bulletin of the Chemical Society of Japan. 2010; 83(10): 1193-7.
  • 21. Mu W, Zhang W, Feng Y, Jiang B, Zhou L. Recent progress in the applications and biotechnological production of D-psychose. Applied Microbiology and Biotechnology. 2012; 94(6): 1461-7.
  • 22. Matsuo T, Suzuki H, Hashiguchi M, Izumori K. D-psychosis is a rare sugar that does not provide energy to growing rats. Journal of Nutritional Science and Vitaminology. 2002; 48(1): 77-80.
  • 23. Sun Y, Hayakawa S, Izumori K. Modification of ovalbumin with a rare ketohexose via Maillard reaction: Effect on protein structure and gel properties. Journal of Agricultural and Food Chemistry. 2004; 52(5): 1293-9.
  • 24. Thacker J, Toyoda Y. Lung and heart-lung transplantation at the University of Pittsburgh: 1982–2009. Clinical Transplants. 2009;179-95.
  • 25. Oshima H, Kimura I, Izumori K. Psychosis content in various foods and its origin. Food Science and Technology Research. 2006; 12(2): 137-43.
  • 26. Izumori K. Izumoring: A strategy for the bioproduction of all hexoses. Journal of Biotechnology. 2006; 124(4): 717-22.
  • 27. Livesey G. The energy value of unavailable carbohydrates and diets: a review and analysis. The American Journal of Clinical Nutrition. 1990; 51(4): 613-37.
  • 28. Cree GM, Perlin AS. Isopropylidene derivatives of D-allulose (D-psicose) and D-erythro-hexopyranose-2,3-diolose. Canadian Journal of Biochemistry and Physiology. 1968; 46(8): 765-0.
  • 29. Matsuo T, Tanaka T, Hashiguchi M, Izumori K, Suzuki H. Metabolic effects of D-psychosis in rats: studies on faecal and urinary excretion and cecal fermentation. Asia Pacific Journal of Clinical Nutrition. 2003;12(2):225-31.
  • 30. Iida T, Hayashi N, Yamada T, Yoshikawa Y, Miyazato S, Kishimoto Y et al. Lack of energy conversion and low colonic fermentability of D-psychose absorbed in the small intestine in humans. Metabolism - Clinical and Experimental. 2010; 59(2): 206-14.
  • 31. Tsukamoto I, Hossain A, Yamaguchi F, Hirata Y, Dong Y. Kamitori K, Intestinal absorption, organ distribution and urinary excretion of the rare sugar, D-psychosis. Drug Design, Development and Therapeutics. 2014;8:1955-64.
  • 32. Hishiike T, Ogawa M, Hayakawa S, Nakajima D, O'Charoen S, Ooshima H, et al. Transepithelial transport of the rare sugar D-psychose in the human intestine. Journal of Agricultural and Food Chemistry. 2013; 61(30): 7381-6.
  • 33. Douard V, Ferraris RP. Regulation of the GLUT5 fructose transporter in health and disease. American Journal of Physiology-Endocrinology and Metabolism. 2008;295:227-7.
  • 34. Harada M, Kondo E, Hayashi H, Suezawa C, Suguri S, Arai M, et al. D-allose and D-psychose potentiate the effect of metronidazole on Trichomonas. Parasitological Research. 2012; 110(4): 1565-7.
  • 35. Chung YM, Lee JH, Kim DY, Hwang SH, Hong YH, Kim SB. Dietary D-psychosis reduced visceral fat mass in high-fat diet-induced obese rats. Journal of Food Science. 2012;77(2):53-8.
  • 36. Yagi K, Matsuo T. Long-term toxicity studies of D-psychosis in rats. Journal of Clinical Biochemistry and Nutrition. 2009;45(3):271-7.
  • 37. Nagata Y, Kanasaki A, Tamaru S, Tanaka K. D-psicose, an epimer of D-fructose, favorably affects lipid metabolism in Sprague-Dawley rats. Journal of Agricultural and Food Chemistry. 2015; 63(12): 3168-76.
  • 38. Roncero I, Alvarez E, Chowen JA, Sanz C, Rabano A, Vazquez P. Expression of glucose transporter isoform GLUT-2 and glucokinase genes in human brain. Journal of Neurochemistry. 2004; 88(5): 1203-10.
  • 39. Funari VA, Herrera VL, Freeman D, Tolan DR. Genes required for fructose metabolism are expressed in cerebellar Purkinje cells. Molecular Brain Research. 2005; 142(2): 115-22.
  • 40. Matschinsky FM. Assessing the potential of glucokinase activators in diabetes therapy. Nature Reviews Drug Discovery. 2009; 8(5): 399-16.
  • 41. Toyoda Y, Ito Y, Tanigawa K, Miwa I. Impairment of glucokinase translocation in cultured hepatocytes from OLETF and GK rats, animal models of type 2 diabetes. Archives of Histology and Cytology. 2000; 63(3): 243-8.
  • 42. Herling AW, Burger HJ, Schwab D, Hemmerle H, Below P, Schubert G. Pharmacodynamic profile of a novel hepatic glucose-6-phosphatase system inhibitor. American Journal of Physiology. 1998;274(6):1087-93.
  • 43. Shiota M, Moore MC, Galassetti P, Monohan M, Neal DW, Shulman GI. Low-fructose ingestion with intraduodenal glucose loading significantly reduces postprandial hyperglycemia and hyperinsulinemia in awake dogs. Diabetes. 2002;51(2):469-78.
  • 44. Watford M. Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel glucokinase activation mechanism. Nutrition Reviews. 2002;60(8):253-7.
  • 45. Raushel FM, Cleland WW. Bovine liver fructokinase: Purification and kinetic properties. Biochemistry. 1977; 16(10): 2169-75.
  • 46. Toyoda Y, Mori S, Umemura N, Futamura Y, Inoue H, Harta T. Suppression of blood glucose levels by D-psychosis in a glucose tolerance test in diabetic rats. Japan Pharmacology & Therapeutics. 2010;38:261-9.
  • 47. Jong-Beom PARK, KIM KI, Eun-Young PARK. Increased apoptosis, matrix degrading enzymes and inflammatory cytokine expression in Annulus Fibrosus cells in genetically modified diabetic rats: implications for disc degeneration. Journal of Neurological Sciences. 2016; 33(3): 415-23.
  • 48. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC. Sugar-sweetened beverages, weight gain, and the incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292(8):927-34.
  • 49. Choi BR, Kwon EY, Kim HJ, Choi MS. Role of d-allulose-containing synbiotics in the alteration of body fat and hepatic lipids in diet-induced obese mice. Nutrients 2018;10(11): 1797.
  • 50. Rutledge AC, Adeli K. Fructose and the metabolic syndrome: Pathophysiology and molecular mechanisms. Nutrition Reviews. 2007;65:13-23.
  • 51. Hossain A, Yamaguchi F, Matsunaga T, Hirata Y, Kamitori K, Dong Y. The rare sugar D-psychosis protects pancreatic beta-islets and thereby improves insulin resistance in OLETF rats. Biochemical and Biophysical Research Communications. 2012;425(4):717-23.
  • 52. Ochiai M, Onishi K, Yamada T, Yamada T, Matsuo T. D-Psychose increases energy expenditure and reduces body fat deposition in rats fed a high-sucrose diet. International Journal of Food Sciences and Nutrition. 2014; 65(2): 245-50.
  • 53. Kim SE, Kim SJ, Kim HJ, Sung MK. D-Psychose, a sugar substitute, inhibits body fat accumulation by altering inflammatory response and lipid metabolism networks in C57BL/6J-ob/ob mice. Journal of Functional Foods. 2017;28:265-74.
  • 54. Baek SH, Park SJ, Lee HG. D-Psychose, a sweet monosaccharide, ameliorates hyperglycemia and dyslipidemia in C57BL/6J db/db mice. Journal of Food Science. 2010; 75(2): 49-53.
  • 55. Matsuo T, Baba Y, Hashiguchi M, Takeshita K, Izumori K, Suzuki H, et al. Reduced body fat deposition with a D-psychosis diet compared with a D-fructose diet. Journal of clinical biochemistry and nutrition. 2001;30:55-65.
  • 56. Matsuo T, Tanaka T, Hassiguchi M, Izumori K, Suzuki H. Effects of oral acute and subchronic feeding of different levels of D-psychosis in rats. Journal of Nutritional Science and Vitaminology. 2002;48(6):512-6.
Back to blog

Allulose sweetener

Allulóz Édesítő eperrel

Allulose granulated sugar

This is the only sugar that does not harm metabolism, but has a particularly beneficial effect on it.

I need this!